Advanced Filter

Filter by Group

Filter by Market Availability

Filter by Biologic Group

Displaying drugs 1 - 25 of 376 in total
Name Weight StructureDesriptionCategories
Abaloparatide3961.0

C174H300N56O49
A parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in postmenopausal women with a high risk of fracture.Bone Density Conservation Agents / Parathyroid Hormones and Analogues / Thyroid Products
Abatacept92300.0

C3498H5458N922O1090S32
A disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease.Selective Immunosuppressants
Abciximab145651.1

C6462H9964N1690O2049S48
A monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention.Platelet Aggregation Inhibitors Excl. Heparin
Adalimumab144190.3

C6428H9912N1694O1987S46
A monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.Tumor necrosis factor alpha (TNF-alpha) inhibitors
Aducanumab146000.0

A monoclonal antibody indicated in the treatment of Alzheimer's disease.Amyloid Beta-directed Antibodies
Aflibercept115000.0

C4318H6788N1164O1304S32
A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy.Antineovascularisation Agents
Agalsidase alfa45351.6

C2029H3080N544O587S27
A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide.alpha-Galactosidase, antagonists & inhibitors / Enzymes / Galactosidases
Agalsidase beta45351.6

C2029H3080N544O587S27
A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide.Enzymes / Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme
Agkistrodon piscivorus antiveninNot AvailableA mixture of antibodies used to treat venomous snake bites from the Crotalinae family (pit vipers).Antivenins
Albiglutide72970.0

C3232H5032N864O979S41
A GLP-1 agonist used to manage type 2 diabetes mellitus.Glucagon-like peptide-1 (GLP-1) analogues
Albumin AggregatedNot AnnotatedAlbumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for...Radioactive Diagnostic Agent
Albumin human66472.2

C2936H4624N786O889S41
A purified form of human serum albumin used to replace lost albumin in patients with hypoalbuminemia, to treat hypovolemia and ascites, and as a part of some diagnostic imaging kits.Blood Substitutes and Plasma Protein Fractions
Albumin iodinated I-125 serumNot AnnotatedA radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume.Radioactive Diagnostic Agent
Albumin iodinated I-131 serumNot AnnotatedA radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume and other diagnostic purposes.Radiopharmaceutical Activity
Albutrepenonacog alfa125000.0

C5077N7846O1588PS67
A recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B.Albumins / Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Drugs that are Mainly Renally Excreted / Enzyme Precursors / Enzymes and Coenzymes / Hemostatics / Protein Precursors / Proteins / Recombinant Proteins
Aldesleukin15314.8

C690H1115N177O202S6
A recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma.Interleukins
Alefacept51801.1

C2306H3594N610O694S26
A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.Selective Immunosuppressants
Alemtuzumab145453.8

C6468H10066N1732O2005S40
A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis.Selective Immunosuppressants
Alglucerase55597.4

C2532H3854N672O711S16
A form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease.Enzymes
Alglucosidase alfa105270.802

C4435H6739N1175O1279S32
An acid alpha- glucosidase (GAA) derivative used as an enzyme replacement therapy for the treatment of Pompe disease in infants and pediatric patients caused by GAA deficiency.Enzymes / Glucosidases / Glycogen Storage Disease Type II / Hydrolytic Lysosomal Glycogen-specific Enzyme
Alipogene tiparvovecNot AnnotatedNot AnnotatedAdeno-associated Viral Vector Therapies / Lipid Modifying Agents / Lipid Modifying Agents, Plain
Alirocumab146000.0

C6472H9996N1736O2032S42
A PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C).Hypercholesterolemia, drug therapy / Hypolipidemic Agents Indicated for Hyperlipidemia / PCSK9 Inhibitor
Alpha-1-proteinase inhibitor44324.5

C2001H3130N514O601S10
A purified form of human alpha-1 proteinase inhibitor used to treat emphysema patients with associated alpha-1 proteinase inhibitor deficiency.Proteinase Inhibitors
Alteplase59000.0

C2569H3928N746O781S40
A recombinant form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli.Enzymes
Amivantamab148000.0

An EGF and MET receptor targeted antibody indicated in the treatment of non-small cell lung cancer with an EGFR 20 exon insertion mutation.Antineoplastic Agents, Immunological
Displaying drugs 1 - 25 of 376 in total